申请人:Cano Montserrat
公开号:US20090062266A1
公开(公告)日:2009-03-05
The invention provides new oxazolidinone compounds of formula (I) wherein A is certain heterocycles optionally substituted; R
1
, R
2
, R
3
and R
4
are independently selected from —H and halogen; X is selected from O, S, NR
9
and CR
9
R
10
; R
9
and R
10
having different meanings; Y is selected from O, S, SO, SO
2
, NO, NR
12
and CR
12
R
13
; R
12
and R
13
having different meanings. It also provides different processes for the preparation of such compounds. Oxazolidinone compounds of formula (I) are active against Gram-positive and some Gram-negative human and veterinary pathogens with a weak monoamine oxidase (MAO) inhibitory activity. They are useful for the treatment of bacterial infections.
该发明提供了具有以下结构式(I)的新的噁唑烷酮化合物,其中A是某些杂环,可以选择性地被取代;R1、R2、R3和R4独立地选自-H和卤素;X选自O、S、NR9和CR9R10;R9和R10具有不同的含义;Y选自O、S、SO、SO2、NO、NR12和CR12R13;R12和R13具有不同的含义。它还提供了制备这些化合物的不同方法。结构式(I)的噁唑烷酮化合物对革兰氏阳性和一些革兰氏阴性人类和兽医病原体具有较弱的单胺氧化酶(MAO)抑制活性。它们可用于治疗细菌感染。